Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at a startup incubator (Symbion) in Copenhagen, just a few kilometers from the center of the city.
Looking for a particular Biosyntia employee's phone or email?
The Biosyntia annual revenue was $7 million in 2026.
Martin Plambech is the CEO of Biosyntia.
11 people are employed at Biosyntia.
Biosyntia is based in Copenhagen, South Denmark.
The NAICS codes for Biosyntia are [54, 541, 541713, 5417, 54171].
The SIC codes for Biosyntia are [873, 87].